<bill session="107" type="h" number="4614" updated="2013-07-14T18:58:30-04:00">
  <state datetime="2002-04-25">REFERRED</state>
  <status>
    <introduced datetime="2002-04-25"/>
  </status>
  <introduced datetime="2002-04-25"/>
  <titles>
    <title as="introduced" type="official">To permit commercial importation of prescription drugs from Canada, and for other purposes.</title>
  </titles>
  <sponsor id="400357"/>
  <cosponsors>
    <cosponsor id="400001" joined="2002-09-25"/>
    <cosponsor id="400007" joined="2002-10-02"/>
    <cosponsor id="400525" joined="2002-05-09"/>
    <cosponsor id="400013" joined="2002-09-26"/>
    <cosponsor id="400553" joined="2002-06-06"/>
    <cosponsor id="400030" joined="2002-05-21"/>
    <cosponsor id="400033" joined="2002-10-15"/>
    <cosponsor id="400527" joined="2002-05-15"/>
    <cosponsor id="400048" joined="2002-05-09"/>
    <cosponsor id="400050" joined="2002-06-25"/>
    <cosponsor id="400067" joined="2002-05-14"/>
    <cosponsor id="400074" joined="2002-06-18"/>
    <cosponsor id="400548" joined="2002-07-25"/>
    <cosponsor id="400080" joined="2002-05-09"/>
    <cosponsor id="400082" joined="2002-06-21"/>
    <cosponsor id="400087" joined="2002-05-07"/>
    <cosponsor id="400100" joined="2002-05-01"/>
    <cosponsor id="400103" joined="2002-05-01"/>
    <cosponsor id="400126" joined="2002-06-18"/>
    <cosponsor id="400133" joined="2002-05-21"/>
    <cosponsor id="400140" joined="2002-05-14"/>
    <cosponsor id="400143" joined="2002-10-01"/>
    <cosponsor id="400163" joined="2002-10-09"/>
    <cosponsor id="400502" joined="2002-05-09"/>
    <cosponsor id="400178" joined="2002-05-01"/>
    <cosponsor id="400183" joined="2002-06-06"/>
    <cosponsor id="400208" joined="2002-06-17"/>
    <cosponsor id="400223" joined="2002-05-15"/>
    <cosponsor id="400227" joined="2002-05-01"/>
    <cosponsor id="400537" joined="2002-06-12"/>
    <cosponsor id="400231" joined="2002-09-11"/>
    <cosponsor id="400237" joined="2002-05-02"/>
    <cosponsor id="400262" joined="2002-06-17"/>
    <cosponsor id="400263" joined="2002-05-09"/>
    <cosponsor id="400513" joined="2002-06-12"/>
    <cosponsor id="400286" joined="2002-05-15"/>
    <cosponsor id="400289" joined="2002-05-01"/>
    <cosponsor id="400290" joined="2002-05-09"/>
    <cosponsor id="400295" joined="2002-05-14"/>
    <cosponsor id="400299" joined="2002-06-17"/>
    <cosponsor id="400301" joined="2002-05-09"/>
    <cosponsor id="400308" joined="2002-05-16"/>
    <cosponsor id="400311" joined="2002-05-15"/>
    <cosponsor id="400316" joined="2002-10-08"/>
    <cosponsor id="400323" joined="2002-06-12"/>
    <cosponsor id="400528" joined="2002-05-09"/>
    <cosponsor id="400366" joined="2002-06-06"/>
    <cosponsor id="400530" joined="2002-07-08"/>
    <cosponsor id="400378" joined="2002-06-21"/>
    <cosponsor id="400387" joined="2002-07-08"/>
    <cosponsor id="400509" joined="2002-09-26"/>
    <cosponsor id="400407" joined="2002-06-21"/>
    <cosponsor id="400422" joined="2002-07-08"/>
    <cosponsor id="400430" joined="2002-07-18"/>
    <cosponsor id="400436" joined="2002-06-21"/>
    <cosponsor id="400438" joined="2002-05-09"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2002-04-25">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2002-05-06">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="107" type="s" number="2244"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Canada"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional investigations"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer protection"/>
    <term name="Counterfeiting"/>
    <term name="Crime and law enforcement"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Foreign trade and international finance"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Governmental investigations"/>
    <term name="Identification devices"/>
    <term name="Import restrictions"/>
    <term name="Imports"/>
    <term name="Labeling"/>
    <term name="Law"/>
    <term name="Marketing"/>
    <term name="Pharmacies"/>
    <term name="Pharmacists"/>
    <term name="Prescription pricing"/>
    <term name="Product safety"/>
    <term name="Restrictive trade practices"/>
    <term name="Wholesale trade"/>
  </subjects>
  <amendments/>
  <summary>4/25/2002--Introduced.
Amends provisions of the Federal Food, Drug, and Cosmetic Act set forth in the Medicine Equity and Drug Safety Act of 2000 to: (1) direct the Secretary of Health and Human Services to promulgate regulations permitting pharmacists and wholesalers to import Food and Drug Administration (FDA)-approved prescription drugs from Canada (currently, from Australia, Canada, Israel, Japan, New Zealand, Switzerland, South Africa, the countries in the European Union and the European Free Trade Association, or other countries designated by the Secretary); and (2) exclude an infused or intravenously injected drug or a drug that is inhaled during surgery.Prohibits discrimination in the sale of prescription drugs by manufacturers to pharmacists or wholesalers, requiring: (1) terms as favorable as those provided to foreign purchasers; and (2) full access to drugs permitted to be imported.Continues the requirement that exported donated prescription drugs may only be reimported by the manufacturer.Permits the Secretary to waive the prohibition against importing a prescription drug or device on a case-by-case basis, particularly those from Canada that are FDA-approved and for limited personal use.Requires a study and report by the: (1) Institute of Medicine of the National Academy of Sciences on the regulatory compliance of importers of drugs; and (2) Comptroller General on how drug prices were affected.</summary>
</bill>
